FindTrial
Sign In

G207

BIOLOGICAL4 trials

Sponsors

MediGene, Gregory K. Friedman, MD, M.D. Anderson Cancer Center

Conditions

Anaplastic AstrocytomaAstrocytomaAstrocytoma, CerebellarBrain DiseasesCentral Nervous System DiseasesCentral Nervous System Neoplasms, MalignantCentral Nervous System Neoplasms, PrimaryCerebellar Neoplasm Malignant Primary

Phase 1

G207 Followed by Radiation Therapy in Malignant Glioma
CompletedNCT00157703
MediGeneMalignant Glioma
Start: 2005-05-31End: 2008-12-31Updated: 2008-12-16
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
CompletedNCT02457845
Gregory K. Friedman, MDAnaplastic Astrocytoma, Cerebral Primitive Neuroectodermal Tumor, Embryonal Tumor +4
Start: 2016-05-31End: 2024-01-31Updated: 2024-01-19
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingNCT03911388
M.D. Anderson Cancer CenterAstrocytoma, Astrocytoma, Cerebellar, Brain Diseases +30
Start: 2019-09-12End: 2027-09-01Target: 24Updated: 2026-09-04

Phase 2

Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas
Not yet recruitingNCT07649070
M.D. Anderson Cancer CenterHigh Grade Gliomas
Start: 2026-11-30End: 2032-12-31Target: 38Updated: 2026-07-29

Related Papers

EXTH-75. IMMUNOVIROTHERAPY WITH PP2A AND PD-1 INHIBITION IN PEDIATRIC HIGH-GRADE GLIOMA
Neuro-Oncology2024-11-01
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy
Neuro-Oncology2024-06-1015 citations
The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study
Journal of Neurosurgery Pediatrics2024-01-134 citations
Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients.
2023-08-1214 citations
Abstract CT018: Phase I immunovirotherapy trial of oncolytic HSV-1 G207 alone or combined with radiation in pediatric high-grade glioma
Cancer Research2021-07-012 citations
EPCT-22 SAFETY AND EFFICACY OF INTRAVENTRICULAR IMMUNOVIROTHERAPY WITH ONCOLYTIC HSV-1 G207 FOR TREATMENT OF LEPTOMENINGEAL DISEASE
Neuro-Oncology2021-06-01
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas
New England Journal of Medicine2021-04-10301 citations
IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS
Neuro-Oncology2018-06-014 citations